These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26615528)

  • 21. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetylation among HIV-positive patients and patients with AIDS: when is fast, fast and slow, slow?
    O'Neil WM; Gilfix BM; DiGirolamo A; Tsoukas CM; Wainer IW
    Clin Pharmacol Ther; 1997 Sep; 62(3):261-71. PubMed ID: 9333101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer.
    Rabstein S; Brüning T; Harth V; Fischer HP; Haas S; Weiss T; Spickenheuer A; Pierl C; Justenhoven C; Illig T; Vollmert C; Baisch C; Ko YD; Hamann U; Brauch H; Pesch B;
    Eur J Cancer Prev; 2010 Mar; 19(2):100-9. PubMed ID: 19996973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
    Bolt HM; Selinski S; Dannappel D; Blaszkewicz M; Golka K
    Arch Toxicol; 2005 Apr; 79(4):196-200. PubMed ID: 15558239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators.
    Majumder M; Sikdar N; Ghosh S; Roy B
    Int J Cancer; 2007 May; 120(10):2148-56. PubMed ID: 17290401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure.
    Garcés-Eisele SJ; Cedillo-Carvallo B; Reyes-Núñez V; Estrada-Marín L; Vázquez-Pérez R; Juárez-Calderón M; Guzmán-García MO; Dueñas-González A; Ruiz-Argüelles A
    J Clin Pharm Ther; 2014 Aug; 39(4):368-75. PubMed ID: 24702251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.
    Ricart E; Taylor WR; Loftus EV; O'Kane D; Weinshilboum RM; Tremaine WJ; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Am J Gastroenterol; 2002 Jul; 97(7):1763-8. PubMed ID: 12135032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
    Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk.
    Chang-Claude J; Kropp S; Jäger B; Bartsch H; Risch A
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):698-704. PubMed ID: 12163321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arylamine N-acetyltransferase 2 polymorphism in the ethnic populations of South India.
    Anitha A; Banerjee M
    Int J Mol Med; 2003 Jan; 11(1):125-31. PubMed ID: 12469231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Full-gene-sequencing analysis of N-acetyltransferase-2 in an adult Indian population.
    Tilak AV; Iyer SN; Mukherjee MS; Singhal RS; Lele SS
    Genet Test Mol Biomarkers; 2013 Mar; 17(3):188-94. PubMed ID: 23216273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory distraction in young and middle-aged adults: a behavioural and event-related potential study.
    Mager R; Falkenstein M; Störmer R; Brand S; Müller-Spahn F; Bullinger AH
    J Neural Transm (Vienna); 2005 Sep; 112(9):1165-76. PubMed ID: 15614427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Auditory distraction, time perception, and the role of age: ERP evidence from a large cohort study.
    Getzmann S; Arnau S; Gajewski PD; Wascher E
    Neurobiol Aging; 2024 Dec; 144():114-126. PubMed ID: 39316947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does age increase auditory distraction? Electrophysiological correlates of high and low performance in seniors.
    Getzmann S; Gajewski PD; Falkenstein M
    Neurobiol Aging; 2013 Aug; 34(8):1952-62. PubMed ID: 23522843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
    Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
    Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of promoter and coding regions of the arylamine N-acetyltransferase 2 (NAT2) gene in the Indonesian population: proposal for a new nomenclature.
    Yuliwulandari R; Sachrowardi Q; Nishida N; Takasu M; Batubara L; Susmiarsih TP; Rochani JT; Wikaningrum R; Miyashita R; Miyagawa T; Sofro ASM; Tokunaga K
    J Hum Genet; 2008; 53(3):201-209. PubMed ID: 18160997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylator phenotyping: the urinary caffeine metabolite ratio in slow acetylators correlates with a marker of systemic NAT1 activity.
    Cribb AE; Isbrucker R; Levatte T; Tsui B; Gillespie CT; Renton KW
    Pharmacogenetics; 1994 Jun; 4(3):166-70. PubMed ID: 7920698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.